Evaluate the effectiveness and safety of Limosilactobacillus fermentum LF61 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
Dietary supplement: Probiotics. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Dietary supplement: Placebo. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Xu fei
Zhengzhou, Henan, China
Change of concentration of antimicrobial peptide LL-37
Detected by Enzyme-Linked Immunosorbent Assay (ELISA).
Time frame: Week 0 and Week 8
Change in calcarein concentration
Detected by Enzyme-Linked Immunosorbent Assay (ELISA).
Time frame: Week 0 and Week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.